
Yatharth Hospital & Trauma Care Services Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- Revenue grew 21% year-on-year in Q3, reflecting robust growth across specialties.
- Nine months FY24 revenue increased 31% year-over-year.
- Revenue growth driven by higher ARPOB and increased complexity of procedures.
- Bed occupancy improved to 52%-53%, expected to rise further with seasonal trends ending.
- Oncology revenue surged more than tenfold YoY; gastroenterology, pulmonology, nephrology, urology, and cardiology also posted strong growth.
- Expansion plans include doubling bed capacity, especially in Noida Extension and Greater Noida hospitals, to optimize occupancy.
- Addition of new specialties such as radiation and robotic surgeries to attract more patients.
- Medical tourism focus expected to significantly boost ARPOB and revenues.
- Anticipate reaching optimized utilization in newer hospitals within 2-3 years, contributing to volume and revenue growth.
- Continued infrastructure upgrades at hospitals to enhance patient experience and competitiveness.
See what Yatharth Hospital & Trauma Care Services management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- There is no mention of any current or planned new fundraising through debt or equity in the transcript.
- The company has highlighted a strong balance sheet with a net cash position of approximately INR 284 crores.
- The acquisition of the Faridabad hospital is being funded through internal resources (corporate reserves and existing cash) without raising new debt.
- The company reported a significant reduction in finance costs due to prudent financial management and lower borrowing expenses.
- No statements indicate plans for issuing equity or raising additional debt for ongoing or future expansions.
- The focus remains on organic and inorganic expansion financed through existing cash reserves and internal accruals.
See what Yatharth Hospital & Trauma Care Services management said on order book — free account, 30 seconds.
Capex plans
Yes- Acquisition of Asian Fidelis Hospital (200-bed super specialty hospital in Faridabad) for INR 1,160 million, expected to complete by March 2024; hospital ready to be operationalized immediately.
- Brownfield expansion plans:
- - Greater Noida Hospital bed capacity to increase from 400 to 600 beds.
- - Noida Extension Hospital bed capacity to increase from 450 to 700 beds.
- Acquired land parcels adjacent to both Greater Noida and Noida Extension hospitals for expansion.
- Expected capex per bed for expansions around INR 70 lakhs.
- Construction/ramp-up to commence soon, with weather improvement in Delhi NCR cited as a factor for starting.
- Strategic focus on doubling bed capacity over the next three years through a combination of greenfield and brownfield expansions.
- No debt financing planned for the Faridabad acquisition; to be funded from cash reserves and corporate reserves.
Track Yatharth Hospital & Trauma Care Services — get its next earnings analysis in your feed
How does Yatharth Hospital & Trauma Care Services rank vs peers in Healthcare Services?
Pro featureHow does Yatharth Hospital & Trauma Care Services rank in Healthcare Services?
Compare Yatharth Hospital & Trauma Care Services against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Yatharth Hospital & Trauma Care Services's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.